Form 4 Tracker
Christopher Gibson

Director · 10 filings · Latest: May 7, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Gibson ChristopherOct 10, 2025
Proposed Sale
$6.04100,000$604.0K
RXRX
Gibson ChristopherSep 25, 2025
Proposed Sale
$4.76100,000$476.0K
RXRX
Gibson ChristopherSep 10, 2025
Proposed Sale
$4.71100,000$471.0K
RXRX
Gibson ChristopherAug 26, 2025
Proposed Sale
$4.84100,000$484.0K
RXRX
Gibson ChristopherAug 11, 2025
Proposed Sale
$5.28617,875$3.3M
RXRX
Gibson ChristopherMar 27, 2025
Proposed Sale
$6.04138,574$837.0K
RXRX
Gibson ChristopherMar 6, 2025
Proposed Sale
$6.3720,000$127.4K
RXRX
Gibson ChristopherMar 5, 2025
Proposed Sale
$6.5820,000$131.6K
RXRX
Gibson ChristopherFeb 6, 2025
Proposed Sale
$8.1220,000$162.4K
RXRX
Gibson ChristopherFeb 5, 2025
Proposed Sale
$7.6820,000$153.6K
RXRX
Gibson ChristopherJan 10, 2025
Proposed Sale
$7.0520,000$141.0K
RXRX
Gibson ChristopherJan 8, 2025
Proposed Sale
$7.3120,000$146.2K
RXRX
Gibson ChristopherDec 5, 2024
Proposed Sale
$7.1220,000$142.4K
RXRX
Gibson ChristopherDec 4, 2024
Proposed Sale
$7.1620,000$143.2K
RXRX
Gibson ChristopherNov 14, 2024
Proposed Sale
$7.3520,000$147.0K
RXRX
Gibson ChristopherNov 13, 2024
Proposed Sale
$7.7420,000$154.8K
RXRX
Gibson ChristopherOct 3, 2024
Proposed Sale
$6.0820,000$121.6K
RXRX
Gibson ChristopherOct 2, 2024
Proposed Sale
$6.1620,000$123.2K
RXRX
Gibson ChristopherSep 5, 2024
Proposed Sale
$6.1420,000$122.8K
RXRX
Gibson ChristopherSep 4, 2024
Proposed Sale
$6.0420,000$120.8K

← Previous

Page 2 of 2